New cancer diagnostic technologies available for Romanian patients

Affidea Center in Fundeni Clinical Institute becomes a Center of Excellence in Oncology and a Reference Center for GE Healthcare in Europe following Affidea's investment of 5 million Euro during the last year in the GE radiological diagnostic equipment from Romania, according to a press release.

2017-01-10 14:10:50

Affidea Center Fundeni will welcome medical teams from the entire Europe, which will come here in order to study the best practices regarding the use of advanced technologies for early diagnosis and monitoring of cancer patients.

75.000 new oncological cases are diagnosed annually in Romania and, according to the World Health Organization, the number is expected to rise significantly over the next two decades.

Over 170.000 patients are coming annually at Affidea Center of Excellence in Oncology for diagnostics or treatment monitoring, 80 per cent of them being oncological patients

"Romania is a still growing market, and the needs for oncological medical services are still very high," said Dimitris Moulavasilis, CEO Affidea Group. "The 5 million Euro investment in Affidea Fundeni Center confirms our commitment to offer Romanian patients high quality medical services and access to leading-edge medical technologies."

Affidea is a large investor and operator in Public Private Partnerships (PPP) in healthcare sector in Europe. The company provides medical imaging services, high performance nuclear medicine, cancer treatment and laboratory analysis in over 175 centers in 14 countries - Poland, Hungary, Romania, Bosnia and Herzegovina, Croatia, Greece, Italy, Turkey, Republic Czech, Portugal, Ireland, Bulgaria, Switzerland and Lithuania.

Affidea Romania has 17 centers and provides a wide range of medical services: high performance imaging investigations, nuclear medicine, together with clinical and laboratory medical investigations.